Pariceract

Overview

Pariceract (LTI-291) is an activator of glucocerebrosidase ( Gcase ), with activation rates of more than 60% (1 μM) and between 10%-20% (0.1 μM). Pariceract can be used for Parkinson's disease and endometriosis research.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Endocrinology | Products > Signaling Pathways > Glycosidase

Product Information

• Catalog No.: HY-104038
• CAS No.: 1919820-28-2
• Molecular Formula: C20H30N4O2
• Molecular Weight: 358.48
• Purity: 99.11%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (6.97 mM); Clear solution
• Availability: In-stock

Source

Original product source